[A new serotonin antagonist derived from lysergic acid in the therapy of hemicrania].
D004873:Ergolines / Q000627:therapeutic use*; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D012702:Serotonin Antagonists
D004873:Ergolines; D012702:Serotonin Antagonists; D008784:Methysergide
Un nuovo antiserotoninico di derivazione lisergica nella terapia dell'emicrania.